Analysts Set AlloVir, Inc. (NASDAQ:ALVR) PT at $18.75

Shares of AlloVir, Inc. (NASDAQ:ALVR – Get Free Report) have received an average recommendation of “Reduce” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the […]

Related Keywords

United States ,America ,Piper Sandler ,Leerink Partnrs ,Metlife Investment Management ,Nasdaq ,Allovir Company Profile ,Charles Schwab Investment Management Inc ,Jpmorgan Chase Co ,Ensign Peak Advisors Inc ,Allovir Inc ,Get Free Report ,Marketbeat Ratings ,Peak Advisors Inc ,Schwab Investment Management ,Life Investment Management ,Get Free ,Allovir Daily ,Allovir ,Nasdaq Alvr ,Alvr ,Medical ,Ratings ,Consensus ,